mitoxantrone has been researched along with Adenocarcinoma, Papillary in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerr, IG | 1 |
| Deangelis, C | 1 |
| Assaad, DM | 1 |
| Hanna, SS | 1 |
1 other study available for mitoxantrone and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Drug extravasation along the route of a peritoneal catheter during intraperitoneal chemotherapy.
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Catheters, Indwe | 1987 |